# Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT

> **NCT04629430** · NA · COMPLETED · sponsor: **University of Virginia** · enrollment: 40 (actual)

## Conditions studied

- Multiple Myeloma
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Non Hodgkin Lymphoma
- Acute Lymphocytic Leukemia
- Hodgkin Lymphoma
- Hodgkin Disease
- Myelofibrosis
- Myelodysplastic Syndromes
- Myeloproliferative Neoplasm
- Sickle Cell Disease
- Mantle Cell Lymphoma

## Interventions

- **OTHER:** Pre-biotic foods/drinks

## Key facts

- **NCT ID:** NCT04629430
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-19
- **Primary completion:** 2022-10-28
- **Final completion:** 2022-10-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04629430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04629430, "Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04629430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*